UNITED THERAPEUTICS Corp (UTHR) › Weighted Average Diluted SharesUNITED THERAPEUTICS Corp (UTHR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2008-12-31: 45.80M2009-12-31: 56.13M2010-12-31: 59.52M2011-12-31: 59.40M2012-12-31: 53.28M2013-12-31: 53.23M2014-12-31: 54.20M2015-12-31: 51.20M2016-12-31: 46.80M2017-12-31: 44.90M2018-12-31: 44.00M2019-12-31: 43.80M2020-12-31: 44.60M2021-12-31: 47.30M2022-12-31: 48.50M2023-12-31: 49.70M2024-12-31: 48.50M2025-12-31: 47.90M47.90M2008-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3147.90M-1.2%2026-02-25From 2025-01-012024-12-3148.50M-2.4%2026-02-25From 2024-01-012023-12-3149.70M+2.5%2026-02-25From 2023-01-012022-12-3148.50M+2.5%2025-02-26From 2022-01-012021-12-3147.30M+6.1%2024-02-21From 2021-01-012020-12-3144.60M+1.8%2023-02-22From 2020-01-012019-12-3143.80M-0.5%2022-02-24From 2019-01-012018-12-3144.00M-2.0%2021-02-24From 2018-01-012017-12-3144.90M-4.1%2020-02-26From 2017-01-012016-12-3146.80M-8.6%2019-02-27From 2016-01-012015-12-3151.20M-5.5%2018-02-21From 2015-01-012014-12-3154.20M+1.8%2017-02-22From 2014-01-012013-12-3153.23M-0.1%2016-02-25From 2013-01-012012-12-3153.28M-10.3%2015-02-24From 2012-01-012011-12-3159.40M-0.2%2014-02-25From 2011-01-012010-12-3159.52M+6.0%2013-02-26From 2010-01-012009-12-3156.13M+22.6%2012-02-28From 2009-01-012008-12-3145.80M—2011-02-24From 2008-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)